BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ), Finward Bancorp (Nasdaq – FNWD)

Brodsky & Smith said it is reminding investors about unspecified investigations and invited shareholders to contact the firm to discuss them at no cost or financial obligation. The notice names no companies, allegations, or investigation details.

Analysis

This is not an investable catalyst on the information provided: the excerpt identifies neither the companies under investigation nor the alleged conduct, transaction terms, or potential damages. A law-firm investigation announcement is not evidence of wrongdoing, a filed complaint, or a material financial liability. Any issuer-specific reaction should therefore be treated as headline noise unless corroborated by a filing, regulatory action, or substantive litigation update. The key downside mechanism—if an affected company is later identified—is not the announcement itself but potential deal uncertainty, management distraction, legal costs, or a change in expected transaction value. No defensible relative-value or options position can be formed without company identities, exposure, and market pricing.

Key Decisions for Investors

• No trade based on this excerpt alone; do not infer which issuers are implicated.
• If an issuer is identified, verify whether a complaint has actually been filed, the alleged conduct and relevant dates, and whether the company has disclosed a material contingency or transaction exposure.
• Reassess only on a concrete catalyst such as a court filing, regulator action, deal revision, or company disclosure; absent that, treat any isolated price weakness as unconfirmed rather than a thesis.